Igas Energy PLC Wythenshawe Hospital Geothermal Scheme (8723A)

TIDMIGAS

RNS Number : 8723A

Igas Energy PLC

30 May 2023

30 May 2023

IGas Energy plc (AIM: IGAS)

("IGas" or "the Company")

Preferred Bidder for Manchester University NHS Foundation Trust - Wythenshawe Hospital Geothermal Scheme

IGas is pleased to announce that, as part of the five tenders submitted through the Carbon and Energy Fund (CEF) Framework in late 2022, GT Energy, IGas' geothermal business, has been selected by Manchester University NHS Foundation Trust (the Trust) as preferred bidder to deliver a geothermal heat solution for the Wythenshawe Hospital.

An Innovation Partnership between GT Energy, the Trust and the CEF will be created to provide a framework for the parties to work together through the project development phases.

Further announcements will be made about the details and timeline of the project once the partnership has been formalised.

About the Carbon and Energy Fund

The Carbon and Energy Fund (CEF) has been specifically created to fund, facilitate and project manage complex energy infrastructure upgrades for the NHS and wider Public Sector.

With a proven track record of more than 60 projects and in-depth experience of procurement, engineering, legal and finance, the CEF is the organisation to successfully guides Public Sector clients through the complex processes involved.

For further information please contact:

   IGas Energy plc                  Tel: [phone] 

Ann-marie Wilkinson, Chief Communications Officer

Investec Bank plc (NOMAD and Joint Corporate Broker) Tel: [phone]

Virginia Bull/Chris Sim

Canaccord Genuity (Joint Corporate Broker) Tel: [phone]

Henry Fitzgerald-O'Connor/James Asensio

   Vigo Consulting                Tel: [phone] 

Patrick d'Ancona/Finlay Thomson/Kendall Hill

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

UPDFLFLRETIRFIV

(END) Dow Jones Newswires

May 30, 2023 02:00 ET (06:00 GMT)